IVERMECTIN MAY PREVENT BINDING OF THE SARS-COV-2 VIRUS TO HUMAN CELLS: TREATMENT/PREVENTION COVID-19

IVERMECTIN MAY PREVENT BINDING OF THE SARS-COV-2 VIRUS TO HUMAN CELLS: TREATMENT/PREVENTION COVID-19Show more

Ivermectin May Prevent Binding Of The SARS-CoV-2 Virus To Human Cells: Treatment/Prevention COVID-19
In this video we will dive into a study that explores a new possible mechanism by which Ivermectin may prevent or treat COVID-19. We will start by reviewing the possible mechanisms of action of Ivermectin including the Imp alpha/beta pathway, viral RNA-dependent RNA polymerase pathway, STAT3 pathway, and CD147 pathway. We will then get into the study. This was a computerized docking study that utilized crystal structures of Ivermectin, the SARS-CoV-2 Spike Protein, and the human ACE2 Receptor. They ran simulations and found that Ivermectin binds to both the Spike protein receptor binding domain (RBD) and ACE2 Receptor. Could this be a new mechanism by which Ivermectin may prevent or treat COVID-19? Check out the video for all the details!

More info: https://dreddymd.com/2021/06/10/breakthrough-ivermectin-inhibits-the-sars-cov-2-spike-protein-from-binding-to-ace2-receptors-in-human-tissue/

Source: https://www.bitchute.com/video/MUEdnWtNdjAK/